Yüksel Ürün, Professor of Medical Oncology at Ankara University School of Medicine shared on LinkedIn:
”Big Pharma is worth trillions. So is the wellness industry.
The difference?
- One is expected to prove that its treatments work.
- The other can often sell hope without proving much at all.
Cancer patients deserve evidence, wherever the claim comes from.”
You can also read:
Yüksel Ürün Shares Findings from the 4th IKCC Global Patient Survey
Yüksel Ürün was recognized among OncoDaily’s The 100 Most Influential People in Oncology in 2025, highlighting his contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15: 100 Influential People in Oncology 2026 – Nominations are Open!
Other articles featuring Yüksel Ürün on OncoDaily.